Intensify therapy with addition of an agent that improves insulin sensitivity (eg, GLP-1 receptor agonist or SGLT2 inhibitor if appropriate) and concurrently implement structured weight-loss interventions, because progressive insulin resistance and beta-cell stress likely explain worsening glycemia.